Showing results (51-60 of 95) with videos related to

Sort By:
Pageof 10
Oncotarget|July 24, 2018
MACROD2 expression predicts response to 5-FU-based chemotherapy in stage III colon cancerEvert van den Broek, Sjoerd H den Uil, Veerle M H Coupé, et al.
Cellular Oncology (Dordrecht, Netherlands)|January 1, 2014
High-level copy number gains of established and potential drug target genes in gastric cancer as a lead for treatment development and selectionMariette Labots, Tineke E Buffart, Josien C Haan, et al.
Pharmacoeconomics|February 7, 2025
Towards Recommendations for Cost-Effectiveness Analysis of Predictive, Prognostic, and Serial Biomarker Tests in OncologyAstrid Kramer, Lucas F van Schaik, Daan van den Broek, et al.
The Journal of Molecular Diagnostics : JMD|September 22, 2020
Diagnostic Strategies toward Clinical Implementation of Liquid Biopsy RAS/BRAF Circulating Tumor DNA Analyses in Patients with Metastatic Colorectal CancerIris van 't Erve, Marjolein J E Greuter, Karen Bolhuis, et al.
Therapeutic Advances in Medical Oncology|August 23, 2024
Early evaluation of the effectiveness and cost-effectiveness of ctDNA-guided selection for adjuvant chemotherapy in stage II colon cancerAstrid Kramer, Marjolein J E Greuter, Suzanna J Schraa, et al.
Therapeutic Advances in Medical Oncology|November 10, 2025
CtDNA-guided de-escalation of adjuvant chemotherapy in stage III colon cancer: early model-based evaluation of cost-effectivenessHaoyue Wang, Astrid Kramer, Marjolein J E Greuter, et al.
Oncotarget|October 13, 2016
Genomic profiling of stage II and III colon cancers reveals APC mutations to be associated with survival in stage III colon cancer patientsEvert van den Broek, Oscar Krijgsman, Daoud Sie, et al.
Nuclear Medicine and Biology|October 4, 2015
Molecular imaging of aurora kinase A (AURKA) expression: Synthesis and preclinical evaluation of radiolabeled alisertib (MLN8237)Jeroen A C M Goos, Joost Verbeek, Albert A Geldof, et al.
Plos One|September 17, 2015
High Prevalence and Clinical Relevance of Genes Affected by Chromosomal Breaks in Colorectal CancerEvert van den Broek, Maurits J J Dijkstra, Oscar Krijgsman, et al.
European Journal of Cancer (Oxford, England : 1990)|December 20, 2020
Quantitative analysis of CDX2 protein expression improves its clinical utility as a prognostic biomarker in stage II and III colon cancerSjoerd H den Uil, Meike de Wit, Robbert J C Slebos, et al.
Pageof 10